Hemostemix (CVE:HEM) Stock Breaks Below 50 Day Moving Average – What’s Next?

by · The Cerbat Gem

Hemostemix Inc. (CVE:HEM – Get Free Report) passed below its 50 day moving average during trading on Wednesday. The stock has a 50 day moving average of C$0.07 and traded as low as C$0.06. Hemostemix shares last traded at C$0.07, with a volume of 269,482 shares.

Hemostemix Trading Down 15.4%

The company has a debt-to-equity ratio of -61.85, a current ratio of 0.13 and a quick ratio of 0.48. The company has a market capitalization of C$11.27 million, a P/E ratio of -2.12 and a beta of 0.31. The firm has a fifty day moving average price of C$0.07 and a 200-day moving average price of C$0.06.

About Hemostemix

(Get Free Report)

Hemostemix Inc, a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, an autologous cell therapy, which is in Phase II clinical trial for the treatment of vascular diseases, such as cardiovascular disease, peripheral arterial disease, angina pectoris, and ischemia. The company also develops NCP-01, which is preclinical trial to evaluate effect on neuropathic pain and motor function recovery.

Read More